Literature DB >> 6108816

Haemodynamics in essential hypertension.

P Lund-Johansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108816     DOI: 10.1042/cs059343s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


× No keyword cloud information.
  23 in total

Review 1.  Use of nifedipine in hypertension and Raynaud's phenomenon.

Authors:  W Kiowski; P Erne; F R Bühler
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Studies on verapamil in the treatment of essential hypertension: a review.

Authors:  K Midtbø; O Hals; O Lauve; J van der Meer; L Storstein
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

3.  Haemodynamic differences in untreated hypertension and hypertension treated with various beta-adrenoceptor antagonists.

Authors:  C Weil; R Waite
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Potentials and limitations of angiotensin converting enzyme inhibition in the treatment of hypertension.

Authors:  J Menard; J B Michel; J C Dussaule; F Alhenc-Gelas; P Corvol
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

5.  Nicardipine hydrochloride in essential hypertension--a controlled study.

Authors:  J Asplund
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Dose finding studies with imidapril--a new ACE inhibitor.

Authors:  M J Vandenburg; E M Mackay; I Dews; T Pullan; S Brugier
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

7.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Cardiovascular response to exercise and regional haemodynamics during treatment with prizidilol hydrochloride (SK & F 92 657) in moderately severe essential hypertension.

Authors:  O Andersson; S Ljungman; G Berglund
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.

Authors:  D H Roberts; Y Tsao; S F Grimmer; P A Winstanley; M L Orme; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

10.  Ketanserin in essential hypertension: effects during rest and exercise.

Authors:  B Persson; T Hedner; G Berglund
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.